UNITI Trademark

Trademark Overview


On Wednesday, July 5, 2017, a trademark application was filed for UNITI with the United States Patent and Trademark Office. The USPTO has given the UNITI trademark a serial number of 87515960. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, July 13, 2020. This trademark is owned by Elstar Therapeutics, Inc.. The UNITI trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, multi-functional proteins for therapeutic use for the treatment of cancer; pharmaceuticals, namely, multi-functional proteins for therapeutic use for the treatment of autoimmune diseases

Pharmaceutical and biological product development consultation relating to multi-functional proteins for therapeutic use for the treatment of cancer; Pharmaceutical and biological product development consultation relating to multi-functional proteins for therapeutic use for the treatment of autoimmune diseases; pharmaceutical and biological product development for others relating to multi-functional proteins, all of the foregoing excluding conducting clinical trials for others
uniti

General Information


Serial Number87515960
Word MarkUNITI
Filing DateWednesday, July 5, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, July 13, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals, namely, multi-functional proteins for therapeutic use for the treatment of cancer; pharmaceuticals, namely, multi-functional proteins for therapeutic use for the treatment of autoimmune diseases
Goods and ServicesPharmaceutical and biological product development consultation relating to multi-functional proteins for therapeutic use for the treatment of cancer; Pharmaceutical and biological product development consultation relating to multi-functional proteins for therapeutic use for the treatment of autoimmune diseases; pharmaceutical and biological product development for others relating to multi-functional proteins, all of the foregoing excluding conducting clinical trials for others
Pseudo MarkUNITY

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 12, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 12, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameElstar Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Monday, July 13, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, July 13, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, July 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 10, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 10, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 31, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, December 31, 2019FINAL REFUSAL E-MAILED
Tuesday, December 31, 2019FINAL REFUSAL WRITTEN
Monday, December 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 8, 2019NON-FINAL ACTION E-MAILED
Saturday, June 8, 2019NON-FINAL ACTION WRITTEN
Monday, May 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 20, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 20, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 20, 2018NON-FINAL ACTION E-MAILED
Tuesday, November 20, 2018NON-FINAL ACTION WRITTEN
Monday, October 29, 2018LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, October 25, 2018ASSIGNED TO LIE
Friday, April 6, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 6, 2018LETTER OF SUSPENSION E-MAILED
Friday, April 6, 2018SUSPENSION LETTER WRITTEN
Monday, April 2, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 2, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 2, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 2, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 2, 2017NON-FINAL ACTION E-MAILED
Monday, October 2, 2017NON-FINAL ACTION WRITTEN
Friday, September 29, 2017ASSIGNED TO EXAMINER
Wednesday, July 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 8, 2017NEW APPLICATION ENTERED IN TRAM